[Neurobiology of Behavioral Addictions.]
[Neurobiology of behavioral addictions.]
Nervenarzt. 2013 Apr 28;
Kiefer F, Fauth-Bühler M, Heinz A, Mann K
Reward learning represents a crucial mechanism in the acquisition and maintenance of addictive behavior. The underlying neurobiological foundations and associated neurobiological pathways are… Continue reading
Suppression of Nicotine-Induced Pathophysiology by an Adenovirus Hexon-Based Anti-Nicotine Vaccine.
Suppression of Nicotine-induced Pathophysiology by an Adenovirus Hexon-based Anti-nicotine Vaccine.
Hum Gene Ther. 2013 Apr 23;
Rosenberg J, De B, Hicks M, Janda K, Kaminsky S, Worgall S, Crystal R
Despite anti-smoking campaigns, cigarette smoking remains a pervasive addiction… Continue reading
Alcohol Use and Cerebral White Matter Compromise in Adolescence.
Alcohol use and cerebral white matter compromise in adolescence.
Addict Behav. 2013 Mar 15; 38(7): 2295-2305
Elofson J, Gongvatana W, Carey KB
Alcohol use is typically initiated during adolescence, a period known to be critical in neurodevelopment. The adolescent… Continue reading
In Vivo Imaging-Based Mathematical Modeling Techniques That Enhance the Understanding of Oncogene Addiction in Relation to Tumor Growth.
In Vivo Imaging-Based Mathematical Modeling Techniques That Enhance the Understanding of Oncogene Addiction in relation to Tumor Growth.
Comput Math Methods Med. 2013; 2013: 802512
Nwabugwu C, Rakhra K, Felsher D, Paik D
The dependence on the overexpression of… Continue reading
[Mechanism of Action of Disulfiram and Treatment Optimization in Prevention of Recurrent Alcoholism].
[Mechanism of action of disulfiram and treatment optimization in prevention of recurrent alcoholism].
Praxis (Bern 1994). 2013 Jan 30; 102(3): 139-46
Mutschler J, Kiefer F
The current frequent use of disulfiram in alcohol relapse prevention, and the possible extension… Continue reading
Enhancing Immunogenicity of a 3’aminomethylnicotine-DT-Conjugate Anti-Nicotine Vaccine With CpG Adjuvant in Mice and Non-Human Primates.
Enhancing immunogenicity of a 3’aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates.
Int Immunopharmacol. 2013 Apr 2;
McCluskie MJ, Pryde DC, Gervais DP, Stead DR, Zhang N, Benoit M, Robertson K, Kim IJ, Tharmanathan T, Merson… Continue reading